Announcing an exciting in person session with US FDA India Office and FDA Center for Biologics (CBER) at C-CAMP focusing on Biologics, Biosimilars, Vaccine development for startups, innovators and researchers at C-CAMP.
Date & Time: July 21, 2pm-5pm
Scheduled talks -
US FDA INO Office Updates - Dr. Sarah McMullen, Director, US FDA India Office
C-CAMP Updates and efforts in Biologics Space – Dr. Nirpendra Singh, Scientist-D & Head, Mass Spectrometry, C-CAMP/BLiSC
FDA Center for Biologics (CBER) Introduction: Perspectives from Covid Vaccine Development and Future Priorities – Dr. Phil Nguyen, International Relations Specialist, US FDA
Talks will be followed by an Open House with Start-up / Innovators / Facility Tour.
Date:
Thursday, July 21, 2022
Banner:
